Congress Materials – Spondyloarthritis Research and Treatment Network (SPARTAN 2025)
2025 Spondyloarthritis Research and Treatment Network | May 9-10 | Toronto, Canada
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Associations Between Clinical Characteristics and Screening Magnetic Resonance Imaging (MRI) Findings: Exploratory Analysis of the Ongoing Phase 4, Multicenter, Randomized, Controlled STAR Study of Biologic-naïve Patients with Psoriatic Arthritis with MRI-confirmed Axial Involvement
This document will be available on May 9th 2025
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.